Dashboard: Supervised consumption sites
- Last updated: 2024-05-15
Data on supervised consumption sites in Canada, including the number of visits, client demographics, client safety, drugs used and overdoses.
On this page
Overview
Supervised consumption sites (SCS) provide a safe, clean space for people to bring their own drugs to use in the presence of trained staff. This prevents accidental overdoses and reduces the spread of infectious diseases, such as HIV.
Since January 2017, every federally exempted SCS in Canada regularly reports its data to Health Canada, and that data is summarized in this dashboard. However, prior to March 2020, there was no standardized reporting format. Because of this, we separate the dashboard into 2 sections. The first section is a general summary of data for all SCS operating at any point between January 2017 and {Date2}. The second section provides detailed information for all SCS operating at any point between March 2020 and {Date2}.
General summary: January 2017 to {Date2}
Overall, results from data reported to Health Canada during this period indicate that there were:
{}
Detailed information: March 2020 to {Date2}
Map of supervised consumption sites
Each SCS is represented by a black dot on the map. Zoom, hover over or select a site to view information about that site.
Notes
- Suppressed – Data suppressed in provinces or territories with low numbers of cases (<10) in order to comply with confidentiality rules.
- Not available (N/A) – Data were not available at the time of this publication.
Map: Text description
| Site | City | Province or Territory | Total visits | Unique clients | Non-fatal overdoses | Number of referrals | Last report date |
|---|
Overdoses
About these tiles
- Please refer to the definitions of indicators for definitions of terms.
- There were {41,538} overdoses at supervised consumption sites. None of them were fatal.
- {10,865} overdoses at SCS required the use of naloxone.
Figure 1: Total non-fatal overdoses and overdoses requiring naloxone use between March 2020 and {Date2} Access and download the data in .csv format
Figure 1 - Text description
| Reporting month | Non-fatal overdoses | Overdoses requiring naloxone |
|---|
Number of visits and clients
{1,658,116}
About these tiles
- Please refer to the definitions of indicators for more details.
- {237,906} unique clients (different people) visited an SCS during the reporting period.
- {1,658,116} total visits were recorded across all SCS, averaging {53,488} visits per month.
- On average, there were {48} visits per day per site, ranging from {0} to {412} visits per day per site.
- On average, there were {30} new clients per month per site, ranging from {0} to {474} new clients per month per site.
The following figure shows the number of total visits and unique clients across all SCS between March 2020 and {Date2}. Hover over or select a portion of the line graph to see the number of total visits or unique clients in each month.
Figure 2: between March 2020 and {Date2} Access and download the data in .csv format
Figure 2 - Text description
| Reporting month | Number of visits | Number of unique clients |
|---|
Personal characteristics of clients
The following graphs show SCS clients by age group and gender. Hover over or select a bar to view the data.
Most clients identify as {male}. For all genders combined, the most common age group was {30-39}.
Figure 3: Gender and age distributions between March 2020 and {Date2}
Gender distribution of SCS clients.
Figure 3 – Gender – Text description
| Gender | Percentage |
|---|
Age distribution of SCS clients
Figure 3 – Age – Text description
| Age group | Percentage |
|---|
Drugs used
This bar chart shows which drugs were most frequently used by clients during their visits to an SCS between March 2020 and {Date2}. {Fentanyl} is the most commonly used drug at supervised consumption sites.
Figure 4: Distribution of drugs used for all visits between March 2020 and {Date2} Access and download the data in .csv format
Figure 4 - Text description
| Type of drug | Percentage |
|---|
Figure 5 shows the number of drug uses overall and by specific drug at SCS between March 2020 and {Date2}. Select a drug from the dropdown menu. Hover over or select a portion of the line graph to see drug uses overall or by drug type in each month.
Figure 5: Number of uses between March 2020 and {Date2} Access and download the data in .csv format
Figure 5 - Text description
| Reporting month | Number of uses |
|---|
Calls for help and service referrals
Calls for help
{2,307}
Calls to emergency medical services (EMS)
{2,336}
Calls for other medical emergencies
{464}
Law enforcement calls
Services and referrals
{481,123}
Services within the site
{41,271}
Services offsite
{82,610}
Services onsite
About these tiles
- Please refer to the definitions of indicators for definitions of terms.
- Please refer to the data limitations for interpretation of services and referrals.
- {2,307} calls were made from SCS to emergency medical services (EMS).
- {2,336} calls were made for other medical emergencies.
- {464} calls were made to law enforcement for police services.
- {481,123} services and referrals were provided within the SCS space.
- {41,271} services and referrals offsite (in a different building or location than the SCS space).
- {82,610} services and referrals were provided onsite, but not in the SCS space.
Reporting SCS per month
The table below shows the number of reporting sites contributing data to each reporting month.
Figure 6: Number of sites reporting per month Access and download the data in .csv format
Figure 6 - Text description
| Reporting month | Reporting sites |
|---|
You might also be interested in
Opioid- and Stimulant-related Harms in Canada
Data on overdoses and deaths involving opioids and/or stimulants from January 2016 to September 2022.
Drug Analysis Service and Cannabis Laboratories
Health Canada’s Drug Analysis Service and Cannabis Laboratory operates laboratories across Canada that analyze suspected illicit substances seized by Canadian law enforcement agencies.
- Date modified: